Microsporidial keratitis after collagen cross-linking

Gautam1, Vishal Jhanji, Gita Satpathy

  • 1Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences , New Delhi , India and.

Abstract

Insights

A rare case of Microsporidium infectious keratitis occurred after collagen crosslinking (CXL) for keratoconus. Prompt microbiological diagnosis and medical treatment, including albendazole, led to a favorable visual outcome.

Area of Science:

  • Ophthalmology
  • Microbiology

Background:

  • Collagen crosslinking (CXL) is a standard treatment for progressive keratoconus.
  • Infectious keratitis is a potential complication following ocular procedures.

Observation:

  • A 36-year-old male developed infectious keratitis with significant vision loss in his left eye six days post-CXL.
  • Clinical examination revealed a central epithelial defect and stromal infiltrates.

Findings:

  • Corneal scrapings stained with Gram and Giemsa confirmed Microsporidia spores.
  • The patient was treated with topical antibiotics, an antifungal agent, and oral albendazole.
  • Corneal debridement was performed twice in the first week.

Implications:

  • This case highlights Microsporidium as a causative agent of infectious keratitis after CXL.
  • Early diagnosis and appropriate medical management, including albendazole, are crucial for successful treatment.
  • Microsporidial keratitis following CXL can be effectively managed with medical therapy alone, preserving visual acuity.

Related Concept Videos